The hepatocyte-specific Trim26 deletion interrupts hepatic metabolism homoeostasis, is accompanied by elevated lipid deposition, the glucose metabolic syndrome, and liver inflammation, and dramatically accelerates the development and progression of NASH. Here, TRIM26 is linked to metabolic dysfunction-associated steatohepatitis.